Double Crane Biotechnology Co. Ltd.

Trineo Biotechnology Co. Ltd

Li-Ming Huang

Chih-Wei Chen

Cheng-Po Huang

Teng-Hai Chen

Kuang-Dee Chen

Cheng-Chiu Tsao

Chao-hsuan Chang

Chieh-Hung Lin

Mon-Tarng Chen

Yen-Chun Liu

Disclosed herein is a novel use of a polysaccharide mixture for the treatment of hyperglycemia and/or disorders related thereto (e.g., diabetes mellitus). The polysaccharide mixture comprises about 30-50% (wt %) of &#x3b2;(1&#x2192;3) glucan and &#x3b2;(1&#x2192;6) glucan, and has a molecular weight of at least 500,000. The polysaccharide mixture may be administered to a subject suffering from hyperglycemia in a dose of about 1 to 1,000 mg/Kg to ameliorate or alleviate symptoms associated with hyperglycemia.

Use of a polysaccharide mixture for treating hyperglycemia

Disclosed herein is an industrial scale process of cultivating cultivatingmycelia. As high as 15 Kg driedmycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting driedmycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).

[object Object]

Growing community of inventors

Tainan, Taiwan

Li-Ming Huang